A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer
Clinical trial NCT01610206 · COMPLETED
Trial details
- NCT number
- NCT01610206
- Sponsor
- Linda R Duska
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2018-06-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.